Zentek (CVE:ZEN) Stock Price Up 19.7% – Should You Buy?

Shares of Zentek Ltd. (CVE:ZENGet Free Report) rose 19.7% on Wednesday . The company traded as high as C$1.47 and last traded at C$1.40. Approximately 107,936 shares were traded during trading, an increase of 54% from the average daily volume of 70,028 shares. The stock had previously closed at C$1.17.

Zentek Stock Up 18.8%

The company has a debt-to-equity ratio of 15.41, a current ratio of 1.00 and a quick ratio of 7.59. The firm’s 50-day moving average price is C$0.78 and its 200 day moving average price is C$0.94. The firm has a market cap of C$149.49 million, a P/E ratio of -17.38 and a beta of 0.34.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Further Reading

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.